Literature DB >> 94391

Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs.

J Kuhlmann, N Rietbrock, B Schnieders.   

Abstract

Glycoside concentrations in plasma and various tissues of dogs were determined after a single and repeated intravenous administration of tritium-labeled digoxin and beta-methyldigoxin. Twenty-four hours after single dosing, the highest concentrations were measured in the kidney. This was followed by the heart, adrenal gland, liver, pancreas, lung, spleen, diaphragm, and skeletal muscle. The glycoside concentration in the brain was low after a single administration of dogoxin. A higher concentration was found after a single dose of the more lipophilic methyldigoxin. After repeated daily administration, the glycoside concentration in plasma and tissues increased continuously and, except for the brain, reached a plateau level after 6 to 8 days. The accumulation factor for both digoxin and methyldigoxin was 2.6. During daily administration for 10 days, the glycoside cconcentration in the brain increased continuously. The mean accumulation factor in all brain areas amounted to 12.4 for methyldigoxin. The concentration of digoxin and methyldigoxin in the tissues decreased, with mean half-lives of 33 and 28 hr, respectively. Glycoside elimination from the brain was clearly slower. A mean half-life of 73 hr was measured for digoxin and of 154 hr for methyldigoxin. The elimination of digoxin was largely renal, while that of methyldigoxin was largely fecal.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94391     DOI: 10.1097/00005344-197903000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Distribution of cardiac glycosides in heart and brain of dogs and their affinity to the (Na+ + K+)-ATPase.

Authors:  J Kuhlmann; E Erdmann; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

2.  Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Authors:  U Mayer; E Wagenaar; J H Beijnen; J W Smit; D K Meijer; J van Asperen; P Borst; A H Schinkel
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment.

Authors:  Antonella Colella; Serena Digiaro; Marco Fiorentino; Beatrice Greco; Mariateresa Sasanelli; Paola Paradies
Journal:  Open Vet J       Date:  2022-06-03

4.  Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.

Authors:  T Jogestrand; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Antiarrhythmic effects of Org 6001 in rats: correlation with plasma and tissue drug concentrations.

Authors:  K Kane; F McDonald; J Parratt; C Timmer; J Vink
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.